Home Main – Policy & Medicine
State Policy 343. Medical Legal 320. Pharmaceutical and Device 277. DOJ 262. Open Payments 261. Physician Payment Sunshine Act 257. Drug Prices 204.
Biden Administration Rescinds Trump Administration Insulin …
Oct 26, 2021 · One of the final healthcare actions made by the Trump Administration has been rescinded by the Biden Administration. On December 23, 2020, the Trump Administration finalized a rule that directed the Department of Health and Human Services (HHS) to take action to require that federally qualified health centers (FQHCs) make insulin and injectable epinephrine available to certain patients at 340B ...
2021 – Policy & Medicine
False Claims Amendments Act of 2021 Continues to Wind Through Congress. Thomas Sullivan Dec 23, 2021 0. Earlier this year, Senator Chuck Grassley and a bipartisan group of senators introduced the False Claims Amendment Act of 2021,…. FDA.
Global – Policy & Medicine
Oct 8, 2024 · Life Science Compliance Update 141. Recent Posts. Global Update on Transparency Reporting: Key Changes and Compliance…. Oct 8, 2024. SCOTUS Rejects Chevron Deference. Oct 7, 2024. Prev Next 1 of 3. Subscribe To Our Daily News. Sign up here to get the latest news and updates delivered directly to your inbox.
Guidelines – Policy & Medicine
FDA Releases Finalized Guidance on Use of Real-World Data in New Drug and…. Thomas Sullivan Feb 26, 2024 0. Recently, the United States Food and Drug Administration (FDA) finalized two guidance documents that outline how sponsors can use…. Guidelines.
FDA – Policy & Medicine
FDA Issues Guidance Documents on Direct-to-Consumer Advertisements. Thomas Sullivan Apr 4, 2024 0. To increase transparency and consumer awareness, the Food and Drug Administration (FDA) issued a final rule to amend its…. FDA.
Editorials – Policy & Medicine
On August 25, 2022, Blood Advances published a new study, authored by Ruemu Birhiray, MD and his daughter, Maya Birhiray, BS, that…
About Us – Policy & Medicine
About Policy & Medicine. Policy & Medicine offers a daily look at legal, regulatory, and compliance issues affecting the pharmaceutical and device industry. Since its inception in 2008, Policy & Medicine has become one of the most widely followed websites in its field. Policy & Medicine provides detailed analysis of many important compliance ...
2022 – Policy & Medicine
Sutter Health Reaches $13 Million Settlement Over False Claims Act…. Thomas Sullivan Dec 21, 2022 0. In October 2022, Sutter Health reached a $13 million settlement to resolve allegations that it violated the False Claims Act by…. CMS.
CME – Policy & Medicine
California Legislation Regarding Linguistic Diversity of CME Headed to…. Thomas Sullivan Oct 10, 2023 0. California recently passed Assembly Bill 470 unanimously in the State Senate. Under this legislation, continuing medical education…. CME.